|
Volumn 111, Issue 6, 2014, Pages 1222-1229
|
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.
a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
KI 67 ANTIGEN;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ARTICLE;
CANCER STAGING;
CELL PROLIFERATION;
CHEMISTRY;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
KAPLAN MEIER METHOD;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
LUNG TUMOR;
LYMPH NODE METASTASIS;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
RETROSPECTIVE STUDY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
ADENOCARCINOMA;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CELL PROLIFERATION;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
KAPLAN-MEIER ESTIMATE;
KI-67 ANTIGEN;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PNEUMONECTOMY;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
|
EID: 84908361044
PISSN: None
EISSN: 15321827
Source Type: Journal
DOI: 10.1038/bjc.2014.402 Document Type: Article |
Times cited : (119)
|
References (0)
|